PROS AND CONS OF AMINOGLUTETHIMIDE FOR ADVANCED POSTMENOPAUSAL BREAST-CANCER

[1] BONFRER JMG, 1983, 3RD P EORTC BREAST C

[2] BRUNING PF, J STEROID BIOCH

[3] AMINOGLUTETHIMIDE (ELIPTEN-CIBA) AS AN INHIBITOR OF ADRENAL STEROIDOGENESIS - MECHANISM OF ACTION AND THERAPEUTIC TRIAL [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (09) : 1239 - +

[4] GOODMAN L, PHARM BASIS THERAPEU, P133

[5] GRIFFITHS CT, 1973, CANCER-AM CANCER SOC, V32, P31, DOI 10.1002/1097-0142(197307)32:1<31::AID-CNCR2820320104>3.0.CO

[6] 2-5

[7] HALL T, 1969, CLIN RES, V12, P402

[8] HARVEY HA, 1979, CANCER, V43, P2207, DOI 10.1002/1097-0142(197906)43:6<2207::AID-CNCR2820430608>3.0.CO

[9] 2-1

[10] HARVEY HA, 1982, CANCER RES, V42, P3451

[1] BONFRER JMG, 1983, 3RD P EORTC BREAST C

[2] BRUNING PF, J STEROID BIOCH

[3] AMINOGLUTETHIMIDE (ELIPTEN-CIBA) AS AN INHIBITOR OF ADRENAL STEROIDOGENESIS - MECHANISM OF ACTION AND THERAPEUTIC TRIAL [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (09) : 1239 - +

[4] GOODMAN L, PHARM BASIS THERAPEU, P133

[5] GRIFFITHS CT, 1973, CANCER-AM CANCER SOC, V32, P31, DOI 10.1002/1097-0142(197307)32:1<31::AID-CNCR2820320104>3.0.CO

[6] 2-5

[7] HALL T, 1969, CLIN RES, V12, P402

[8] HARVEY HA, 1979, CANCER, V43, P2207, DOI 10.1002/1097-0142(197906)43:6<2207::AID-CNCR2820430608>3.0.CO

[9] 2-1

[10] HARVEY HA, 1982, CANCER RES, V42, P3451